Story
Jefferies Valuation Presents a Paradox as Two Models Show Conflicting Outcomes

Summary
An analysis of Jefferies Financial Group (JEF) reveals a stark valuation conflict, with one model based on classic principles suggesting the stock is overvalued, while another indicates potential upside of over 40%.
Shares of Jefferies Financial Group (JEF) present a valuation puzzle for investors, with two distinct analytical models arriving at sharply conflicting conclusions. An analysis based on classic value investing principles suggests the stock is overvalued, while a model focused on modern earnings power indicates significant potential upside from its price of $46.24 as of September 24, 2026.
The Bear Case: A Graham-Style Analysis
A valuation model based on the principles of Benjamin Graham, the influential economist known as the "father of value investing," calculates an intrinsic value of $38.57 for Jefferies. This suggests the stock is currently trading at a 14.7% premium to what this framework would consider fair value, according to an analysis by Investing.com.
This pessimistic view is driven by two key factors Graham's formula penalizes: earnings volatility and high leverage. Jefferies' earnings per share have been cyclical, swinging from $6.13 in fiscal 2021 to $1.10 in 2023. Furthermore, its debt-to-equity ratio of 366%, while typical for an investment bank, is a figure that traditional value models view with caution.
The Bull Case: A Modern Value Perspective
In contrast, a multi-model approach that weighs normalized earnings power, similar to the philosophy of Warren Buffett, arrives at a fair value of $65.43. This implies a potential upside of 41.5% from current levels. The analysis, which references the InvestingPro Fair Value model, is supported by several key metrics:
Ad- Price-to-Book Ratio: At 1.0x, the stock is trading at the stated value of its net assets.
- PEG Ratio: A low PEG ratio of 0.38x suggests the market may be underpricing the company's earnings growth trajectory.
- Revenue Recovery: Revenue has rebounded from a low of $4.70 billion in fiscal 2023 to $7.34 billion in fiscal 2025, approaching its 2021 peak.
- Dividend Yield: The stock offers a 3.5% dividend yield, providing income to investors.
Market Context and Analyst Views
The bull case finds support from Wall Street analysts. In June 2026, Goldman Sachs raised its price target on Jefferies to $66, citing a 59% year-over-year increase in its M&A advisory backlog. Similarly, UBS has reiterated a Buy rating, highlighting the firm's market share gains in global advisory, where it has climbed from 11th to 6th in league tables since 2018.
Adding to the long-term picture is a strategic relationship with Sumitomo Mitsui Financial Group, which has indicated its intent to increase its stake in Jefferies. However, bears can point to a return on equity of 7.7%, which is below the levels typically sought by discerning value investors, and earnings that remain below their 2021 highs.
Read next
More on Stocks
Semiconductor Stocks Surge on AI Demand, Outpacing Broader Market
Semiconductor stocks including Intel, AMD, and Arm Holdings posted double-digit gains this week, driven by sustained investor enthusiasm for artificial intelligence infrastructure. The rally significantly widened the outperformance of AI-focused investment strategies against benchmark indexes like the S&P 500.

Insider Disclosures Show Major Buy at Goosehead, $58M Sale at Aspen Aerogels
Recent SEC filings revealed significant insider transactions, highlighted by a $7.1 million purchase of Goosehead Insurance stock by a major shareholder and a $58.1 million sale of Aspen Aerogels shares by an institutional owner.

Costco Stock Stalls Despite Earnings Beat as High Valuation Weighs on Sentiment
Costco reported quarterly revenue and profit that topped Wall Street estimates, but its shares remained flat as investors focused on a normalizing growth outlook and the stock's premium valuation.

Evonik Shares Surge Over 8% on Report of BASF Merger Approach
Shares in German specialty chemicals firm Evonik Industries jumped after a Financial Times report stated that rival BASF has made a formal merger proposal. The news sparked takeover speculation, pushing the stock to a new 52-week high.